This is published at the 2019 National Organization of Rare Disorders (NORD) Breakthrough Summit and was the first of several NHS posters and papers at medical conferences.
by
by
This is published at the 2019 National Organization of Rare Disorders (NORD) Breakthrough Summit and was the first of several NHS posters and papers at medical conferences.
Every donation, no matter the size, helps us continue our mission.
© Desmoid Tumor Research Foundation (DTRF) | c/o CliftonLarsonAllen LLP, 50 Tice Blvd, Suite 175, Woodcliff Lake, NJ 07677